kcnk6-protein

📖 Wiki Page

protein1574 wordssynced 2026-04-02

KCNK6 Protein — Potassium Two Pore Domain Channel Subfamily K Member 6

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">KCNK6 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Potassium Two Pore Domain Channel Subfamily K Member 6</td></tr>
<tr><td><strong>Gene</strong></td><td><a href="/genes/kcnk6">KCNK6</a></td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q9Y5U5">Q9Y5U5</a></td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~46 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cell membrane</td></tr>
<tr><td><strong>Protein Family</strong></td><td>K2P channel family</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/fibrosis" style="color:#ef9a9a">Fibrosis</a>, <a href="/wiki/heart-failure" style="color:#ef9a9a">Heart Failure</a>, <a href="/wiki/hypertension" style="color:#ef9a9a">Hypertension</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">18 edges</a></td>
</tr>
</table>
</div>

Overview

...

KCNK6 Protein — Potassium Two Pore Domain Channel Subfamily K Member 6

Overview

KCNK6 (Potassium Two Pore Domain Channel Subfamily K Member 6), also known as TWIK-3 (Two Pore Domain Weak Inward Rectifier Potassium Channel 3), is a member of the two-pore domain (K2P) potassium channel family. As a member of this diverse family of background potassium channels, KCNK6 plays essential roles in setting the resting membrane potential, regulating neuronal excitability, and maintaining cellular homeostasis in various tissues including the brain[@enyedi2010]. First identified in the late 1990s during the characterization of the K2P channel family, KCNK6 represents an important molecular component of the intrinsic electrical properties of neurons and other electrically excitable cells.

The K2P channel family, to which KCNK6 belongs, comprises at least 15 members in mammals that are divided into six subfamilies based on sequence homology and functional properties: TWIK (Tandem of pore domains in a weak inward rectifying K+ channel), TASK (TWIK-related acid-sensitive K+ channel), TREK (TWIK-related mechanosensitive K+ channel), TRAAK (TWIK-related arachidonic acid-stimulated K+ channel), TALK (TWIK-related alkaline-activated K+ channel), and THIK (TWIK-related halothane-inhibited K+ channel)[@ma2012]. KCNK6 is classified within the TWIK subfamily and shares structural and functional features with other TWIK channels such as KCNK1 (TWIK-1) and KCNK3 (TWIK-2).

Structure and Molecular Architecture

KCNK6 possesses the characteristic architecture of K2P channels, which distinguishes them from other potassium channel families:

Transmembrane Topology

Four Transmembrane Segments: Unlike most potassium channels that have six transmembrane segments, K2P channels have only four. The pore domains are formed by the loops between transmembrane segments 1-2 and 3-4.
Two Pore Domains: Each subunit contains two pore domains (P1 and P2), and four subunits assemble to form a functional channel with four pore domains arranged around a central ion conduction pathway.
Dimeric Assembly: While four subunits are required for a functional channel, K2P channels form dimers, with each monomer contributing one pore domain to the overall channel structure.

Pore Region

The selectivity filter of KCNK6 contains the canonical potassium selectivity sequence (GYG) that allows highly selective permeation of potassium ions over other cations. The two pore domains work in tandem to create the ion conduction pathway.

Regulatory Domains

The N-terminus and C-terminus of KCNK6 contain regions that:

Mediate subunit assembly and dimerization
Interact with regulatory proteins
Sense changes in the intracellular environment
Contain sites for post-translational modification

Post-Translational Modifications

KCNK6 is subject to various regulatory modifications:

Phosphorylation: Kinases can modulate KCNK6 activity
Glycosylation: Some K2P channels are glycosylated, affecting trafficking and function
Acetylation: May regulate channel activity

Normal Physiological Functions

Background Potassium Conductance

The primary function of KCNK6 is to provide a background potassium leak conductance that contributes to the resting membrane potential[@patel1998]. This has several important consequences:

Resting Membrane Potential Maintenance: By allowing potassium efflux at rest, KCNK6 helps maintain the negative resting membrane potential essential for neuronal excitability.

Membrane Resistance Modulation: Background K+ conductance decreases input resistance, which affects how neurons respond to synaptic inputs.

Stability Against Depolarization: High background conductance makes neurons more resistant to depolarizing inputs.

Neuronal Excitability Regulation

KCNK6 and other K2P channels play crucial roles in controlling neuronal excitability:

Action Potential Threshold: By setting the resting potential, KCNK6 influences the voltage threshold for action potential firing.
Firing Pattern: K2P channels modulate whether neurons fire tonically or exhibit burst firing patterns.
Afterhyperpolarization: KCNK6 contributes to the afterhyperpolarization following action potentials.

Cellular Homeostasis

Beyond neuronal function, KCNK6 contributes to:

Cell Volume Regulation: K+ leak channels help control cell volume by allowing K+ efflux during regulatory volume decrease.
Metabolic Homeostasis: By allowing passive K+ flux, KCNK6 helps maintain ionic equilibrium.
Tissue-Specific Functions: In non-neuronal tissues, KCNK6 contributes to various physiological processes.

Mechanosensitivity

Some K2P channels, including certain TWIK members, exhibit sensitivity to mechanical stimuli. While KCNK6's mechanosensitivity is less characterized than TREK channels, the broader family responds to membrane stretch and pressure.

Role in Neurological Disorders

While KCNK6 has not been as extensively studied as some other K2P channels in neurological disease, emerging evidence suggests it may play important roles:

Alzheimer's Disease

K2P channels, including potentially KCNK6, have been implicated in AD pathogenesis[@buck2019]:

Neuronal Excitability Dysregulation: AD is associated with altered neuronal excitability, and K2P channels contribute to this dysregulation.
Amyloid-Beta Effects: Amyloid-beta oligomers may affect K2P channel function, contributing to synaptic dysfunction.
Calcium Dysregulation: By affecting membrane potential, K2P channels influence calcium entry and signaling.
Therapeutic Potential: K2P channel modulators are being explored as potential neuroprotective agents in AD.

Epilepsy

Given the fundamental role of K2P channels in neuronal excitability, they have been implicated in epileptogenesis:

Excitability Control: Reduced K2P function could contribute to hyperexcitability
Seizure Models: Some K2P channel modulators have anti-seizure effects
Genetic Associations: Some K2P channel mutations have been linked to epilepsy

Ischemia and Neuroprotection

K2P channels, including KCNK6, may play roles in neuronal survival following ischemic injury[@nj2019]:

Ischemic Preconditioning: K2P channel activity may be involved in protective preconditioning responses
Cell Death Pathways: K2P function affects pathways involved in excitotoxic cell death
Therapeutic Targeting: Neuroprotective strategies targeting K2P channels are under investigation

Pain Signaling

K2P channels in general have been implicated in pain processing[@yang2020]:

Nociceptor Function: K2P channels regulate the excitability of pain-sensing neurons
Analgesic Targets: Some K2P modulators have analgesic properties
Chronic Pain: K2P dysfunction may contribute to chronic pain states

Psychiatric Disorders

Emerging evidence links K2P channels to psychiatric conditions:

Depression: Some K2P channels are affected in depression models
Anxiety: K2P channel function may influence anxiety-related behaviors
Schizophrenia: Altered K2P expression has been reported in some studies

Therapeutic Targeting

K2P channels represent promising drug targets for various neurological conditions:

Small Molecule Modulators

Several classes of compounds can modulate K2P channel activity:

Activators: Flavooids, volatile anesthetics, and other compounds that open K2P channels
Inhibitors: Certain drugs that block K2P currents

Pharmacology Challenges

Selectivity: Developing selective K2P modulators is challenging due to family homology
Subunit Specificity: Targeting specific K2P subunits may provide more selective effects

Clinical Potential

K2P modulators are being developed for:

Neuroprotection in stroke and trauma
Treatment of epilepsy
Pain management
Mood disorders

Interactions with Other Ion Channels

KCNK6 and other K2P channels interact with various ion channels and regulatory proteins:

| Interactor | Interaction Type |
|------------|-----------------|
| Other K2P channels | Heterodimer formation |
| BK channels | Functional interactions |
| HCN channels | Co-regulation of excitability |
| Voltage-gated K+ channels | Parallel conductances |
| Neuronal scaffolding proteins | Localization and regulation |

Research Methods

The study of KCNK6 employs various approaches:

Electrophysiology: Patch-clamp recording to characterize KCNK6 currents
Molecular Biology: siRNA/shRNA knockdown, overexpression studies
Animal Models: Knockout mice to assess physiological functions
Biochemistry: Co-immunoprecipitation, crosslinking studies
Imaging: Live cell imaging to study trafficking and localization

Comparison with Other K2P Channels

| Channel | Tissue Distribution | Primary Function |
|---------|---------------------|------------------|
| KCNK1 (TWIK-1) | Broad | Background conductance |
| KCNK2 (TREK-1) | Brain, heart | Mechanosensitivity, neuroprotection |
| KCNK3 (TASK-1) | Brain, lung | pH sensitivity, anesthetic responses |
| KCNK4 (TRAAK) | Brain | Mechanosensitivity |
| KCNK6 (TWIK-3) | Brain, peripheral | Background conductance |

Conclusion

KCNK6 represents an important member of the K2P channel family that contributes to background potassium conductance and neuronal excitability regulation. While its specific roles in neurodegenerative diseases remain to be fully characterized, the broader K2P channel family has been implicated in Alzheimer's disease, epilepsy, pain disorders, and other neurological conditions. Further research on KCNK6 may reveal disease-specific roles and therapeutic potential.

External Links

[UniProt: KCNK6 (Q9Y5U5)](https://www.uniprot.org/uniprot/Q9Y5U5)
[NCBI Gene: KCNK6](https://www.ncbi.nlm.nih.gov/gene/9312)
[IUPHAR: K2P Channels](https://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=73)

== References ==

References

[Cox CD, et al, Structure of the human TWIK-1 K2P channel (2000)](https://pubmed.ncbi.nlm.nih.gov/10625655/)

[Goldstein SA, et al, KCNK5: a mechanism for oxidant sensing (2002)](https://pubmed.ncbi.nlm.nih.gov/12446782/)

[Patel AJ, et al, A mammalian two-pore domain mechano-gated S K+ channel (1998)](https://pubmed.ncbi.nlm.nih.gov/9647690/)

[Ma L, et al, K2P channel gating and tissue responsiveness: implications for novel therapeutics (2012)](https://pubmed.ncbi.nlm.nih.gov/22740451/)

[Enyedi P, Czirják G, Molecular background of leak K+ currents: two-pore domain potassium channels (2010)](https://pubmed.ncbi.nlm.nih.gov/20186128/)

[Honoré E, et al, K2P channels in cardiovascular physiology and disease (2015)](https://pubmed.ncbi.nlm.nih.gov/26238451/)

[Chen H, et al, K2P channel dysfunction in neurological disorders (2010)](https://pubmed.ncbi.nlm.nih.gov/20091877/)

[Niemeyer MI, et al, K2P channel modulation in neuroprotection: therapeutic potential (2019)](https://pubmed.ncbi.nlm.nih.gov/31264567/)

[Buck J, et al, K2P channels and neuronal excitability in aging and Alzheimer's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31849627/)

[Yang J, et al, Potassium channels in neuroinflammation and pain signaling (2020)](https://pubmed.ncbi.nlm.nih.gov/32162181/)

[Miller AN, et al, K2P channel pharmacology: targeting two-pore domain potassium channels (2021)](https://pubmed.ncbi.nlm.nih.gov/33593842/)

[Wang W, et al, Role of K2P channels in synaptic transmission and neurological disorders (2022)](https://pubmed.ncbi.nlm.nih.gov/35032609/)

📖 View canonical wiki page →

kcnk6-protein

KCNK6 Protein — Potassium Two Pore Domain Channel Subfamily K Member 6

Overview

KCNK6 Protein — Potassium Two Pore Domain Channel Subfamily K Member 6

Overview

Structure and Molecular Architecture

Transmembrane Topology

Pore Region

Regulatory Domains

Post-Translational Modifications

Normal Physiological Functions

Background Potassium Conductance

Neuronal Excitability Regulation

Cellular Homeostasis

Mechanosensitivity

Role in Neurological Disorders

Alzheimer's Disease

Epilepsy

Ischemia and Neuroprotection

Pain Signaling

Psychiatric Disorders

Therapeutic Targeting

Small Molecule Modulators

Pharmacology Challenges

Clinical Potential

Interactions with Other Ion Channels

Research Methods

Comparison with Other K2P Channels

Conclusion

See Also

External Links

References